LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides

Int J Mol Sci. 2021 Feb 9;22(4):1741. doi: 10.3390/ijms22041741.

Abstract

Long noncoding RNAs (lncRNAs) represent key regulators of gene transcription during the inflammatory response. Recent findings showed lncRNAs to be dysregulated in human diseases, such as inflammatory bowel disease, diabetes, allergies, asthma, and cancer. These noncoding RNAs are crucial for immune mechanism, as they are involved in differentiation, cell migration and in the production of inflammatory mediators through regulating protein-protein interactions or their ability to assemble with RNA and DNA. The last interaction can occur in cis or trans and is responsible for all the possible lncRNAs biological effects. Our proposal is to provide an overview on lncRNAs roles and functions related to immunity and immune mediated diseases, since these elucidations could be beneficial to untangle the complex bond between them.

Keywords: autoimmune diseases; immunity; inflammation; long noncoding RNA; transcript regulation.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity / genetics*
  • Animals
  • Autoimmune Diseases / genetics*
  • Autoimmune Diseases / immunology
  • Cell Movement / genetics
  • Cell Movement / immunology
  • Gene Expression Regulation / immunology*
  • Humans
  • Immunity, Innate / genetics*
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation Mediators / metabolism
  • Models, Animal
  • Oligonucleotides / metabolism
  • Protein Interaction Maps / genetics
  • Protein Interaction Maps / immunology
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Transcription, Genetic / immunology

Substances

  • Inflammation Mediators
  • Oligonucleotides
  • RNA, Long Noncoding